Cerevance vs Emulate
Side-by-side comparison of AI visibility scores, market position, and capabilities
Cerevance is a CNS drug discovery company using proprietary NETSseq single-nucleus transcriptomics to identify cell-type-specific drug targets in human brain tissue; lead program CVN424 for Parkinson's disease completed Phase 2;
About
Cerevance is a clinical-stage biopharmaceutical company founded in 2016 and headquartered in Cambridge, Massachusetts, focused on developing novel therapeutics for central nervous system (CNS) diseases. The company's core technological advantage is its NETSseq (Nuclear Enrichment for Transcriptome Sequencing) platform, which profiles gene expression at the individual cell-type level in post-mortem human brain tissue. By identifying transcriptional and epigenetic differences between specific cell types — such as dopaminergic neurons versus medium spiny neurons — Cerevance can discover drug targets that are active in disease-relevant cell populations and largely silent in others, enabling greater target selectivity and potentially better tolerability than broad CNS agents.
Pioneering organ-on-chip platform installed in 150+ labs including 17 of the top 25 biopharma companies; launched AVA™ high-throughput 96-chip system in 2025 and holds the only FDA ISTAND-accepted DILI Organ-Chip.
About
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the microstructure and function of human organs. Founded in 2013 as a spin-out from the Wyss Institute at Harvard University, Emulate's chips model the liver, intestine, lung, kidney, brain, and other organ systems with a fidelity that animal models and traditional cell culture cannot match. The technology was originally developed to reduce drug development attrition rates caused by poor translation from animal studies to human clinical outcomes.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.